Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,821.65 -2.85 -0.10%
FTSE 100 6,803.87 +48.24 0.71%
DAX 8,472.20 +16.37 0.19%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,194.60 +14.54 0.28%
  • Fund Type: SICAV
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Credit Suisse SICAV Lux Equity Biotechnology

+ Add to Watchlist

CLTLU:LX

254.7500 USD 2.3200 0.92%

As of 11:25:04 ET on 05/21/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Credit Suisse SICAV Lux Equity Biotechnology (CLTLU)

Open: 254.7500 High - Low: 254.7500 - 254.7500 Primary Exchange: Luxembourg
Volume: 0 52-Week Range: - Beta vs NBI: -

ETF Chart for CLTLU

No chart data available.
  • CLTLU:LX 254.7500
  • 1D
  • 1M
  • 1Y
252.4300
Interactive CLTLU Chart

Previous Close

Fund Profile & Information for CLTLU

Credit Suisse SICAV (Lux) Equity Biotechnology is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in a portfolio of equity securities of biotechnology companies worldwide.

Inception Date: Telephone: -
Managers: IRENE B PUTTNER
Web Site: www.credit-suisse.com

Fundamentals for CLTLU

NAV -
Assets (M) (on 2013-05-17) 169.2045
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for CLTLU

No dividends reported

Performance for CLTLU

1-Month - 1-Year -
3-Month - 3-Year -
Year To Date - 5-Year -
Expense Ratio -

Top Fund Holdings for CLTLU

Filing Date: 03/27/2013
Name Position Value % of Total
Gilead Sciences Inc 260,484 12,430,296 8.108%
Celgene Corp 107,638 12,188,927 7.951%
Biogen Idec Inc 52,745 9,635,457 6.285%
Amgen Inc 84,973 8,510,046 5.551%
BioMarin Pharmaceutical Inc 130,444 7,873,600 5.136%
Vertex Pharmaceuticals Inc 141,000 7,731,030 5.043%
Onyx Pharmaceuticals Inc 85,000 7,525,050 4.908%
Regeneron Pharmaceuticals Inc 44,000 7,519,600 4.905%
Alexion Pharmaceuticals Inc 74,752 7,020,708 4.580%
Incyte Corp Ltd 265,000 6,007,550 3.919%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil